Celltrion
068270.KS
£86.68
Share price
-1.89%
Change (1 day)
-17.32%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): £2.48
According to Celltrion 's latest financial reports the company's current EPS (TTM) is £2.28. In 2022 the company made an earnings per share (EPS) of £2.22 a decrease over its 2021 EPS that were of £2.64.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | £2.48 | 11.68% |
| 2022 | £2.22 | -15.84% |
| 2021 | £2.64 | 12.77% |
| 2020 | £2.34 | 70.79% |
| 2019 | £1.37 | 15.63% |
| 2018 | £1.19 | -33.13% |
| 2017 | £1.77 | 141.17% |
| 2016 | £0.74 | 8.28% |
| 2015 | £0.68 | 11.28% |
| 2014 | £0.61 | 16.37% |
| 2013 | £0.52 | -67.42% |
| 2012 | £1.61 | 84.22% |
| 2011 | £0.87 | 62.13% |
| 2010 | £0.54 | 80.61% |
| 2009 | £0.30 | -559.63% |
| 2008 | -£0.06497 | -123.16% |
| 2007 | £0.28 |